These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36407985)

  • 21. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
    Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patent Foramen Ovale Closure in the Setting of Cryptogenic Stroke: A Meta-Analysis of Five Randomized Trials.
    Garg L; Haleem A; Varade S; Sivakumar K; Shah M; Patel B; Agarwal M; Agrawal S; Leary M; Kluck B
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2484-2493. PubMed ID: 29805084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical vs. drug therapy in patients with patent foramen ovale and cryptogenic stroke.
    Liu Y; Wu Y; Xiong L
    Herz; 2021 Jun; 46(3):250-254. PubMed ID: 32394019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.
    Han Y; Zhang X; Zhang F
    J Cardiothorac Surg; 2020 Jan; 15(1):11. PubMed ID: 31918738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Akobeng AK; Abdelgadir I; Boudjemline Y; Hijazi ZM
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):165-173. PubMed ID: 29602258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.
    Kasner SE; Thomassen L; Søndergaard L; Rhodes JF; Larsen CC; Jacobson J
    Int J Stroke; 2017 Dec; 12(9):998-1004. PubMed ID: 29090661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.
    Rengifo-Moreno P; Palacios IF; Junpaparp P; Witzke CF; Morris DL; Romero-Corral A
    Eur Heart J; 2013 Nov; 34(43):3342-52. PubMed ID: 23847132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials.
    Schulze V; Lin Y; Karathanos A; Brockmeyer M; Zeus T; Polzin A; Perings S; Kelm M; Wolff G
    Clin Res Cardiol; 2018 Sep; 107(9):745-755. PubMed ID: 29500568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent Stroke Reduction with Patent Foramen Ovale Closure versus Medical Therapy Based on Patent Foramen Ovale Characteristics: A Meta-Analysis of Randomized Controlled Trials.
    Garg A; Thawabi M; Rout A; Sossou C; Cohen M; Kostis JB
    Cardiology; 2019; 144(1-2):40-49. PubMed ID: 31574522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Transcatheter Closure of Patent Foramen Ovale in Clinical Practice.
    Alkhouli M; Van Houten HK; Yao X; Holmes DR
    J Am Heart Assoc; 2023 Aug; 12(15):e030321. PubMed ID: 37489748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM; Carroll JD
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
    Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated meta-analysis.
    Xu HB; Zhang H; Qin Y; Xue F; Xiong G; Yang L; Bai H; Wu J
    J Neurol Sci; 2018 Jul; 390():139-149. PubMed ID: 29801875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis.
    Ntaios G; Papavasileiou V; Makaritsis K; Michel P
    Int J Cardiol; 2013 Oct; 169(2):101-5. PubMed ID: 24041984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta-Analysis, and New Insights From the CLOSE Study.
    Turc G; Calvet D; Guérin P; Sroussi M; Chatellier G; Mas JL;
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patent foramen ovale and cryptogenic stroke: the hole story.
    Furlan AJ; Jauss M
    Stroke; 2013 Sep; 44(9):2676-8. PubMed ID: 23908069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke.
    Kim M; Kim S; Moon J; Oh PC; Park YM; Shin DH; Lee YB; Lee JY; Hwang HY; Kang WC
    J Interv Cardiol; 2018 Jun; 31(3):368-374. PubMed ID: 28833599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure.
    Liu K; Song B; Palacios IF; Inglessis-Azuaje I; Deng W; McMullin D; Wang X; Lo EH; Xu Y; Buonanno FS; Ning M
    JACC Cardiovasc Interv; 2020 Dec; 13(23):2745-2752. PubMed ID: 33303111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated meta-analysis of closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
    Nasir UB; Qureshi WT; Jogu H; Wolfe E; Dutta A; Majeed CN; Tan WA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):187-193. PubMed ID: 30905408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
    Kwong JS; Lam YY; Yu CM
    Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.